Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LEO Science & Tech Hub is the Boston-based R&D innovation unit of LEO Pharma, a global leader in medical dermatology. Established in 2016 in Cambridge, Massachusetts, the Hub serves as a catalyst for early-stage collaborations with academia, startups, and technology companies to advance precision medicine in skin health. Its primary focus areas include non-invasive biomarkers, advanced imaging, drug delivery technologies, and digital health solutions. By leveraging LEO Pharma's deep expertise in dermatology, the Hub identifies and funds innovative projects that aim to transform the diagnosis and treatment of chronic skin conditions like atopic dermatitis and psoriasis. The unit operates with a high degree of flexibility to invest in and co-develop risky, cutting-edge technologies that can be translated into clinical solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LEO Science Hub.